Close
Back to REPL Stock Lookup

Replimune (REPL) – Hot Corp. News

Dec 5, 2023 07:03 AM Replimune (REPL) study of RP1 in combination with cemiplimab did not meet either of the two primary endpoints

Back to REPL Stock Lookup